- Risk assets closed higher yesterday after a weak opening
- Sanofi has announced yet another approval for blockbuster drug Dupixent, this time in Europe for the treatment of atopic dermatitis in children between the ages of six months and five years
- A volatile session for core bonds yesterday with yields moving higher on the day
Overview
Committed to you, your financial future, and your journey there
Overview
Investment Solutions
Pension Solutions
SDIO
Application Forms – Intermediaries
Creating impact for your clients, their financial goals, and their future
Overview
Focused on your organisation, funding its growth, and unlocking its full potential
Debt Capital Markets
Probate Services
Dedicated to institutional wealth, stakeholder value, and a sustainable future
Overview
Investment Services
Stewardship
Supportive of you, your custodial vision, and your philanthropic goals
X